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Unfortunately, the original version of this article [1] con-
tained an error. Figures  2 and 7 were the incorrect ver-
sions. They have been corrected in the original article 




*Correspondence:  marzen@niboch.nsc.ru 
1 Institute of Chemical Biology and Fundamental Medicine SB RAS, 8, 
Lavrentiev Ave., Novosibirsk 630090, Russian Federation
Full list of author information is available at the end of the article
Fig. 2 Development of LIVP-GFP infection in various tumour cells. 
Development of LIVP-GFP infection in RLS (green circles), RLS-40 (red 
circles), KB-3-1 (violet squares), KB-8-5 (black line with open squares) and 
melanoma B-16 (blue triangles) tumour cells at MOI of 1 (a) and MOI 
of 10 (b). Cells were incubated with virus for 1 h, washed with PBS 
and incubated up to the analysis in IMDM supplemented with 2 % 
FBS. Viral titre was measured by PFU assay. Data of three independent 
experiments are presented
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Fig. 7 Effect of LIVP-GFP treatment on the immune responses of 
tumour-bearing mice. a Summary data showing a significant increase 
of the number of IFN-γ-ransecreting splenocytes in LIVP-GFP-treated 
mice (n = 6) with RLS-40 or with melanoma B-16 tumours. Compari-
son of immune-related proteins GMC-SF (b) and IL-6 (c) in the blood 
serum of RLS-40 bearing mice during the treatment with LIVP-GFP 
(the experimental scheme was shown in Fig. 5a): red circles and blue 
squares for RLS-40 bearing mice treated with LIVP-GFP and PBS, 
respectively; black triangles healthy mice receiving PBS. The levels of 
cytokines in the blood serum were measured by ELISA. For each day, 
the value of mean ± SEM is shown
The online version of the original article can be found under 
doi:10.1186/s12967-016-1002-x.
